A ‘breadth of protection:’ Novavax’s newly-approved COVID vaccine arms the U.S. with a new weapon against Omicron BA.5 subvariant

Novavax says its vaccine prompted ‘broad immune responses’ against all COVID variants, including BA.5, in clinical data. Read More

Read More?

Post is imported from RSS feed, by one of our guest editors. G6 does not edit or moderate the content. G6 is not responsible for your actions. No rights owned by G6. To remove the post, please email us at [email protected]

No Comments

Sorry, the comment form is closed at this time.